Email this article Cardiovascular risk factors in psoriatic and rheumatoid arthritis
- Authors: Rebrov A.P.1, Nikitina N.M.1, Gaydukova I.Z.1, Rebrov AP2, Nikitina NM2, Gaidukova IZ3
-
Affiliations:
- State Medical University, Saratov
- Regional hospital, Saratov
- Issue: Vol 83, No 5 (2011)
- Pages: 20-24
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30832
- ID: 30832
Cite item
Full Text
Abstract
Aim. To study the role of conventional and new factors of cardiovascular risk in development of atherosclerosis in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PA).
Material and methods. Sixty patients with psoriatic arthritis, 414 RA patients and 79 healthy controls entered the trial. All of them had no manifestations of cardiovascular diseases. Screening was made of the leading risk factors of cardiovascular diseases and cardiovascular complications, thickness of the complex intima-media (TIM) of the carotid arteries, vascular wall stiffness were measured, vasoregulatory function of the endothelium, markers of endothelial damage were examined.
Results. Patients with psoriatic and rheumatoid arthritis were found to have increased TIM of the carotid arteries, high incidence of atherosclerotic plaques, increased stiffness, damage of the vascular wall, affected endothelial vasoregulation. These alterations were associated with high arthritis activity, systemic manifestations, seropositivity by rheumatoid factor (in RA), presence of entesitis, uveitis and dactilitis (in psoriatic arthritis), dislipidemia, arterial hypertension (AH).
Conclusion. To determine cardiovascular risk in patients with arthritis, it is necessary to consider not only standard risk factors (dislipidemia and AH), but also severity of systemic inflammation, arterial stiffness, endothelial damage and ability of the vascular wall to relax reflecting endothelial dysfunction.
Material and methods. Sixty patients with psoriatic arthritis, 414 RA patients and 79 healthy controls entered the trial. All of them had no manifestations of cardiovascular diseases. Screening was made of the leading risk factors of cardiovascular diseases and cardiovascular complications, thickness of the complex intima-media (TIM) of the carotid arteries, vascular wall stiffness were measured, vasoregulatory function of the endothelium, markers of endothelial damage were examined.
Results. Patients with psoriatic and rheumatoid arthritis were found to have increased TIM of the carotid arteries, high incidence of atherosclerotic plaques, increased stiffness, damage of the vascular wall, affected endothelial vasoregulation. These alterations were associated with high arthritis activity, systemic manifestations, seropositivity by rheumatoid factor (in RA), presence of entesitis, uveitis and dactilitis (in psoriatic arthritis), dislipidemia, arterial hypertension (AH).
Conclusion. To determine cardiovascular risk in patients with arthritis, it is necessary to consider not only standard risk factors (dislipidemia and AH), but also severity of systemic inflammation, arterial stiffness, endothelial damage and ability of the vascular wall to relax reflecting endothelial dysfunction.
About the authors
Andrey Petrovich Rebrov
Email: andreyrebrov@yandex.ru
Natal'ya Mikhaylovna Nikitina
Inna Zurabievna Gaydukova
A P Rebrov
State Medical University, SaratovState Medical University, Saratov
N M Nikitina
State Medical University, SaratovState Medical University, Saratov
I Z Gaidukova
Regional hospital, SaratovRegional hospital, Saratov
References
- Gladman D. D., Farewell V. T., Wong К. Mortality studies in psoriatic arthritis: results from a single outpatient center. Prognostic indicators for death. Arthr. and Rheum. l998; 41: 1103-1010.
- Maradit-Kremers H., Nicola P. J., Crowson C. S. et al. Cardiovascular death in rheumatoid arthritis: A population - based study. Arthr. and Rlieum 2005; 52:722-732.
- Gonzalez-Gay M. A., Gonzalez-Juanatey C., Martin X. Rheumatoid arthritis: The disease associated with accelerated atherogenesis. Semin. Arthr. Rheum. 2005; 35: 8-17.
- Del Rincon I. D., Williams K., Stern M. P. et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthr. and Rheum. 2001; 44 (12): 2737-2745.
- Erb N. X., Banks M. J., Rowe I. F.et al. Unavoidable and modifiable risk factors for ischaemic heart disease (IHD) in rheumatoid arthritis (RA) (Abstr.) EULAR J. 2001; 60 (Suppl. 1): 18.
- Antivalle M., Mutti A., Randisi G. et al. Prevalence of metabolic syndrome, risk factor clustering, inflammatory markers, and cardiovascular morbidity in rheumatoid arthritis and spondyloarthritis. Ann. Rheum. Dis. 2006; 65 (Suppl. II): 160.
- McEntegart A., Capell H. A., Creran D. et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001; 409 (6): 640- 644.
- Псориатический артрит. B кн.: Насонов Е. Л. (ред.). Клинические рекомендации. Ревматология. М.: ГЕОТАР-Медиа; 2005. 92-98.
- Олюнин Ю. А. Оценка активности и эффективности терапии ревматоидного артрита. В кн.: Международные индексы оценки активности, функционального статуса и качества жизни больных ревматическими заболеваниями. M.: Изд. группа "Ассоциации ревматологов России"; 2007. 3-12.
- Оганов Р. Г. Факторы риска сердечно-сосудистых заболеваний. В кн.: Оганов Р. Г., Фомина И. Г. Болезни сердца: Руководство для врачей. М: Литера; 2006. 35-53.
- Бадокин В. В. Псориатический артрит: клиника, диагностика, лечение: Автореф. дис. ... д-ра мед. наук. М., 2003.
- Hodis H. N., Mack W. J., LaBree L. et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med. 1998; 128 (4): 262-269.
- Lund L. Digital pulse plethysmography in studies of the haemodynamic response to nitrates: a survey of recording methods and principles of analysis. Acta Pharmacol. Toxicol. 1986; 59: 79-96.
- Парфенов А. С. Экспресс-диагностика сердечно-сосудистых заболеваний. Мир измерений 2006; 6: 74-82.
- Han С., Robinson D. W., Hackett M. V. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol. 2006; 33: 2167-2172.
- Jones S. M., Harris C. P. D., Lloyd J. et al. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann. Rheum. Dis. 2000; 59 (5): 904-909.
- Neiman A. L., Shin D. В., Wang X. et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J. Am. Acad. Dermatol. 2006; 55: 829-835.
- Бадокин В. В., Янышева А. В., Александрова Е. Н. и др. Риск развития сердечно-сосудистых заболеваний при псориатическом артрите. Тер. арх. 2009; 6: 41-47.
- Gisondi P., Tessari G., Conti A. et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br. J. Dermatol. 2007; 157 (1): 68-73.
- Насонов Е. Л. Иммунологические вопросы атеросклероза. Тер. арх. 2002, 5: 80-85.
- Takazawa К., Tanaka N., Fujita M. Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmograph waveform. Hypertension 1998; 32: 365-370.
- Насонов Е. Л., Попкова Т. В. Кардиоваскулярные проблемы в ревматологии. Науч.-практ. ревматол. 2004; 1: 80- 85.
- Arnett D. K., Evans G. W., Riley W. A. Arterial stiffness: a nero-cardiovascular risk factor? Am. J. Epidemiol. 1994; 140: 669-682.
- Chen C. H., Nevo E., Fetics B. et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 1997; 95: 1827-1836.
- Kals J., Kampus P., Kals M. Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects. Scand. J. Clin. Lab. Invest. 2007; 67: 536-544.
Supplementary files
